INTS — Intensity Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00- $28.23m
- $21.16m
- 15
- 11
- 72
- 22
Annual cashflow statement for Intensity Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -6.03 | -7.9 | -7.58 | -10.5 | -16.3 |
| Non-Cash Items | 0.672 | 0.892 | 1.35 | 3.97 | 3.15 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.012 | 0.177 | 0.757 | -0.633 | -2.1 |
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -5.37 | -6.83 | -5.48 | -7.21 | -15.2 |
| Other Investing Cash Flow Items | 4.56 | 0 | 0 | -6.02 | 6.35 |
| Sale/Maturity of Investment | |||||
| Change in Net Investments | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | 4.56 | 0 | 0 | -6.02 | 6.35 |
| Financing Cash Flow Items | 0.025 | 0.05 | 0 | 22.4 | -0.653 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 6.29 | 2.05 | 2.25 | 20.5 | 2.9 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 5.49 | -4.78 | -3.23 | 7.24 | -5.97 |